Millennium Management
EDSA icon

Millennium Management’s Edesa Biotech EDSA Stock Holding History

Millennium Management’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,555
Closed -$16K – 6666
2022
Q3 		$16K Sell
2,555
-5,125
-67% -$63.1K ﹤0.01% 6518
2022
Q2 		$86K Buy
+7,680
New +$113K ﹤0.01% 5995
2018
Q4 		– Sell
-403
Closed -$24K – 3833
2018
Q3 		$24K Buy
+403
New +$25.7K ﹤0.01% 3826

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Millennium Management's EDSA Position: Q4 2022 in Review

Millennium Management sold out of Edesa Biotech (EDSA) in Q4 2022, closing a stake of 2,555 shares — an estimated $16K sold.

Millennium Management first reported a position in EDSA in Q3 2018 and held it in 3 quarters. The position peaked at $86K in Q2 2022. 22 funds tracked by Wall St. Rank hold EDSA as of Q4 2022.

  • Millennium Management reported no remaining Edesa Biotech position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 2,555 Edesa Biotech shares in Q4 2022, an estimated $16K.
  • Millennium Management first reported a position in Edesa Biotech in Q3 2018 and held it in 3 quarters.
  • Millennium Management's Edesa Biotech position peaked at $86K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.